Drawing for MNAZYME

USPTO serial 79099130

MNAZYME

Reviewed by CopyMark Law Group

Reg. 4148404Status 404
Filing date
Status date
Registration date
May 29, 2012
Examiner
PENDLETON, CAROLYN A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MNAZYME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Perry

David M. Perry Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103-6998

Goods and services

ClassDescriptionStatusFirst use
001chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants for non-medical purposes; enzymes for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; nucleic acids; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; microbial chemicals used in environmental monitoringSECTION 71 - CANCELLED
005pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disordersSECTION 71 - CANCELLED
010surgical and medical apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapySECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 28, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 28, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
Oct 18, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB
Sep 16, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 16, 2019INPCINVALIDATION PROCESSED
Sep 4, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 4, 2019C71TCANCELLED SECTION 71
May 29, 2017REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 10, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 16, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 25, 2012GPNXNOTIFICATION PROCESSED BY IB
Sep 15, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 30, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 30, 2012FIMPFINAL DISPOSITION PROCESSED
Aug 29, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 29, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 13, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 8, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 7, 2012ALIEASSIGNED TO LIE
Jan 24, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 3, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 3, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 7, 2011RFNPREFUSAL PROCESSED BY IB
Jul 20, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Jul 19, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 19, 2011RFRRREFUSAL PROCESSED BY MPU
Jul 18, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 17, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2011DOCKASSIGNED TO EXAMINER
Jul 16, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance